Targeting the Gut Microbiome in Cirrhosis

0Citations
Citations of this article
N/AReaders
Mendeley users who have this article in their library.
Get full text

Abstract

The components of the human gut microbiome are bacteria, viruses, fungi, and archaea. Microbial composition and function are modulated by interventions and medications such as alcohol intake, changes in diet or cultural factors, medications, such as proton pump inhibitors and antibiotics, as well as a liver transplant. Several studies observed a strong association between changes in microbiome and severity of liver disease and complications such as hepatic encephalopathy and acute on chronic liver failure. The chapter includes an overview of (1) methods to measure the presence of gut bacteria in stool samples, (2) approaches to target the gut microbiome, and (3) studies of fecal microbiota transplantation in human cirrhosis. The clinical interest in the microbiome also includes the potential for microbiome-based biomarkers to inform clinical decision-making.

Cite

CITATION STYLE

APA

Krag, A., & Bajaj, J. S. (2022). Targeting the Gut Microbiome in Cirrhosis. In Portal Hypertension VII: Proceedings of the 7th Baveno Consensus Workshop: Personalized Care in Portal Hypertension (pp. 311–319). Springer International Publishing. https://doi.org/10.1007/978-3-031-08552-9_26

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free